# APIXABAN
> **ANDA213903** · Abbreviated New Drug Application (Generic) · Sponsor: ZHEJIANG YONGNING PHARMACEUTICAL CO LTD · Approved 2022-06-21
## Drug
- **FDA Application Number:** ANDA213903
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APIXABAN
- **Generic name:** Apixaban
- **Active ingredients:** APIXABAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ZHEJIANG YONGNING PHARMACEUTICAL CO LTD
- **First approval:** 2022-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213903)
---
*AI Analytics · CC0 1.0*